Association of HLA Type with Stevens-Johnson Syndrome Induced by Methazolamide Treatment.
- Author:
Jung Il MOON
1
;
Jin Ho SEO
;
Chan Kee PARK
Author Information
1. Department of Ophthalmology, St.Mary's Hospital, College of Medicine, The Catholic University of Korea, #62, Yoido-dong, Youngdeungpo-ku, Seoul, 150-713, Korea.
- Publication Type:Original Article
- Keywords:
Stevens-Johnson syndrome;
Methazolamide;
HLA typing
- MeSH:
Asian Continental Ancestry Group;
Histocompatibility Testing;
HLA-A2 Antigen;
Humans;
Leukocytes;
Methazolamide*;
Ophthalmology;
Stevens-Johnson Syndrome*
- From:Journal of the Korean Ophthalmological Society
2000;41(10):2241-2246
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
There have been reports between Stevens-Johnson syndrome (SJS)induced by methazolamide treatment and genetic background especially in Japanese and Korean descent.We report 6 cases of SJS and the results of HLA (human leukocyte antigen)typing that suggest a relationship between genetic background and SJS induced by methazolamide treatment. We observed 6 patients as the subjects of this research, who had been suffering from SJS induced by methazolamide treatment at the Department of Ophthalmology, Catholic University.SJS appeared about 2 weeks after the patient started taking methazolamide (100 or 200 mg/d).After 15~30 days of treatment, they recovered with no serious complication.The results of HLA typing carried out 6 patients that all of the patients had HLA-A2, 5 patients were HLA-Cw1 and HLA-B59. Methazolamide should be carefully prescribed in patients of Japanese or Koreans descent and should not prescribe sulfonamide in SJS patients. A further systematic research on more cases is required to explaining ethnic peculiarity of the syndrome.
